AU Patent

AU2018201037A1 — Process for the preparation of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide

Assigned to Nerviano Medical Sciences SRL · Expires 2018-03-01 · 8y expired

What this patent protects

Abstract The present invention relates to a process for the preparation of N-[5-(3,5-difluoro-benzyl)-1 H-indazol-3-yl]-4-(4-methyl piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide. Novel solid forms of this compound, their utility in treating diseases caused by deregulat…

USPTO Abstract

Abstract The present invention relates to a process for the preparation of N-[5-(3,5-difluoro-benzyl)-1 H-indazol-3-yl]-4-(4-methyl piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide. Novel solid forms of this compound, their utility in treating diseases caused by deregulated protein kinase activity and pharmaceutical compositions containing them are also object of the present invention 9948751 1 (GHMatters) P98505.AU.1

Drugs covered by this patent

Patent Metadata

Patent number
AU2018201037A1
Jurisdiction
AU
Classification
—
Expires
2018-03-01
Drug substance claim
No
Drug product claim
No
Assignee
Nerviano Medical Sciences SRL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.